Bedolla R, Prihoda TJ, Kreisberg JI, Malik SN, Krishnegowda NK, Troyer DA, Ghosh PM. Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Aktactivation. Clin. Cancer Res., 2007. 13(13): 3860-3867.
Wang, Y., Kreisberg, J.I., Bedolla, R., Mikhailova, M., deVere White, R.W. and Ghosh, P.M. A 90kDa fragment of Filamin A promotes Casodexinduced growth inhibition in Casodex-resistant androgen-receptor positive C4-2 prostate cancer cells. Oncogene, 2006. 26: 6061-6070.
Shi, X.-B., Xue, L. Tepper, C.G., Gandour-Edwards, R., Ghosh, P., Kung, H.J. and deVere White, R.W. The oncogenic potential of a prostate cancer-derived androgen receptor mutant. The Prostate, 2007. 67(6): 591-602.
Vinall, R.L., Hwa, K., Ghosh, P., Pan, C-X., Lara, P.N. Jr. and deVere White, R.W. Combination Treatment Of Prostate Cancer Cell Lines With Bioactive Soy Isoflavones (GCP) And Perifosine Causes Increased Growth Arrest And/Or Apoptosis. Clinical Cancer Res., 2007. 13: 6204-6216.
Wang, Y., Kreisberg, J.I. and Ghosh, P.M. Cross-talk between the Androgen Receptor and the Phosphatidylinositol 3-kinase/Akt pathway in Androgen-Independent Prostate Cancer. Current Cancer Drug Targets., 2007. 7: 591-604.
Kamat, A., Ghosh, PM, Glover, RL, Zhu, B, Yeh, CK, Choudhury, GG and Katz, MS. Reduced Expression of Epidermal Growth Factor Receptors in. Journal of Gerontology, 2008. 63(7): 683-692.
Wang, Y, Mikhailova, M, deVere White, RW, and Ghosh, PM. Regulation of androgen receptor transcriptional activity by rapamycin. Oncogene, 2008. 27(56): 7106-7117.
Chamie, K, Ghosh, PM, Koppie, TM, Romero, V, Troppmann, C,and deVere White, RW. The effect of sirolimus on PSA kinetics in male renal transplant recipients without prostate cancer. American Journal of Transplantation, 2008. 8(12): 2668-2673.
Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, de Vere White RW, Ghosh PM. Nuclear vs Cytoplasmic localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases. Clinical Cancer Research, 15(3): 788-796, 2009.
Khan IH, Ghosh PM, Zhao J, Ziman M, Sweeney C, Kung HJ and Luciw PA. Microbead Arrays for the Analysis of ErbB Receptor Tyrosine Kinase Activation and Dimerization in Breast Cancer Cells. ASSAY and Drug Development Technologies, 8(1): 27-36, 2010.
Chen H, Libertini SJ, Wang Y, Kung HJ, Ghosh PM, Mudryj M. ERK Regulates Calpain 2 Induced AR Cleavage To LMW Forms in CWR22 Relapsed Prostate Tumor Cell Lines. J Biol Chem, 285(4): 2368-74, 2010.
Chen L, Siddiqui S, Bose S, Mooso B, Asuncion A, Bedolla RG, Vinall R, Tepper CG, Gandour-Edwards R, Shi X, Lu XH, Siddiqui J, Chinnaiyan AM, Mehra R, Devere White RW, Carraway KL 3rd, Ghosh PM.. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate–resistant prostate cancer cells. Cancer Research, 70(14): 5994-6003, 2010.
Chen H, Libertini SJ, George M, Dandekar S, Tepper CG, Al-Bataina B, Kung H-J, Ghosh PM, Mudryj M. Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines. Endocrine-related cancers, 17(4): 857-873, 2010.
Mooso BA, Loredo GA, Madhav A, Johnson S, Roy M, Moore ME, Moy CV, Mehta RG, Vaughan ATM, Ghosh PM. Androgen Receptor regulation of Vitamin D receptor in response of prostate cancer cells to 1α(OH)D5. Genes & Cancer, 2010, in press.